Advertisement

Serum Selenium, Micro and Macrovascular Complications in Diabetic Patients

  • C. da Silva
  • J. Poupon
  • P. J. Guillausseau
  • P. Chappuis

Abstract

The following study has been undertaken to establish if antiradicalar agents (1) and serum selenium are linked to hypertension and micro and macrovascular complications in diabetic patients. We also addressed the question of any nutritional role of selenium in diabetes, by searching for any relation between selenium and BMI (Body Mass Index) in patients with type 1 insulin dependent (IDDM) and type 2 non insulin dependent (NIDDM).

Keywords

Diabetic Patient Macrovascular Complication Serum Selenium NIDDM Patient IDDM Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D.V Godin, S.A. Wohaieb, M.E. Garnett and A.D. Goumeniouk, Mol. Cell. Biol. 84, 223–231 (1988).Google Scholar
  2. 2.
    J. Arnaud, P. Chappuis, M.C. Jaudon, J. Bellanger and A. Favier, Ann. Biol Clin. 51, 589–604 (1993).Google Scholar
  3. 3.
    R.M. Walter, J.Y. Uriu-Hare, K.L. Olin, M.H. Oster, M.S. Bradley, D. Anawalt, J.W. Critchfield and C.L. Keen, Diabetes Care 14, 1050–1056 (1991).CrossRefGoogle Scholar
  4. 4.
    J.T. Salonen, R. Salonen and M. Ihanainen, Am. J. Clin. Nutr. 48, 1226–1232 (1988).Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • C. da Silva
    • 1
  • J. Poupon
    • 1
  • P. J. Guillausseau
    • 2
  • P. Chappuis
    • 1
  1. 1.Laboratoire Central de BiochimieHôpital LariboisièreParisFrance
  2. 2.Service de Médecine BHôpital LariboisièreParisFrance

Personalised recommendations